RECENT NEWS
Leica Biosystems and Bio-Techne expand partnership to automated spatial multiomics
Bio-Techne has announced an expansion of the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD), and Leica Biosystems.
UKHSA launches call for evidence to tackle rising TB
The UK Health Security Agency (UKHSA) is launching a call for evidence to help shape the next 5-year Tuberculosis (TB) National Action Plan for England, which will run from 2026 to 2031. The latest data for England show that TB rates are rising, and TB epidemiology is changing.
Biotia partners with Mayo Clinic on infectious disease diagnostics
Biotia has announced a joint development agreement with Mayo Clinic to propel precision medicine in infectious disease diagnostics.
Cross-sector coalition makes case for community diagnostics
The British In Vitro Diagnostics Association (BIVDA) - along with leading industry and health charities - has launched a new policy declaration that highlights the value of community diagnostics and their role in a future neighbourhood NHS.
Diagnexia and Stratipath to expand access to AI-based cancer diagnostics
Digital pathology firm Diagnexia and Stratipath AB, a pioneer in AI-based cancer diagnostics, have announced a strategic partnership to bring Stratipath Breast, an AI-based prognostic risk profiling tool for invasive breast cancer, to pathology laboratories, hospitals, and healthcare providers across the UK and Europe.
US District Court vacates FDA rule on laboratory-developed test procedure regulation
The Association for Molecular Pathology and pathologist Michael Laposata MD PhD, have announced a favourable ruling in their lawsuit against the U.S. Food and Drug Administration over the regulation of laboratory-developed test (LDT) procedures.
National Cancer Institute collaboration to advance AI-powered biomarker research
The National Cancer Institute (NCI), part of the U.S. National Institutes of Health (NIH), is to partner with cancer diagnostics firm Lunit to explore innovative applications of AI in cancer research.
MHRA showcases next phase of regulatory science
The Medicines and Healthcare products Regulatory Agency (MHRA) recently hosted an event for the seven newly established Centres of Excellence in Regulatory Science and Innovation (CERSIs) to showcase how their projects will help drive advancements in healthcare.
New Chair elected at BIVDA
Richard Hames, General Manager of Werfen UK, has been elected Chair of the British In Vitro Diagnostics Association (BIVDA).
Record number of imported dengue cases reported by UKHSA
New data from the UK Health Security Agency (UKHSA) show that last year imported dengue cases in England, Wales and Northern Ireland (EWNI) reached their highest level since dengue surveillance began in 2009. All cases are linked to travel abroad.
The 10 Year Plan - Clinical Innovations Expo
Thornhill Healthcare Events' 10th face-to-face event will see the main topic of discussion be the government's forthcoming 10-year plan and the part clinical innovations will play in delivering improved patient care and true service transformation.
Advanced Instruments to acquire and merge with Nova Biomedical
Advanced Instruments has announced a definitive agreement to acquire fellow biotechnology company Nova Biomedical.
Diagnexia launches Global Education and Outreach Programme to bridge diagnostic gaps
Digital pathology service provider Diagnexia has launched a Global Education and Outreach Programme, a transformative initiative aimed at enhancing education, diagnostic access and healthcare outcomes in regions with limited pathology resources.
Citylabs 4.0 boosts health innovation in Manchester
Citylabs 4.0, a new £42million specialist laboratory and office space, is now officially open at Manchester University NHS Foundation Trust’s (MFT) Oxford Road hospital campus, in a further boost to the city’s position as a leading hub for health innovation.
Philips and Ibex expand partnership
Royal Philips has announced the expansion of its partnership with Ibex Medical Analytics and a new release of Philips IntelliSite Pathology Solution to further accelerate the adoption of AI-enabled digital pathology.
Techcyte unveils unified anatomic and clinical digital pathology platform
Digital pathology firm Techcyte has launched Fusion, its first open, standards-based, SaaS platform designed to unify anatomic and clinical pathology workflows.
UKHSA highlights pathogens of greatest risk to public health
A new Priority Pathogens reference tool aims to support national funders of research and development into diagnostics, vaccines and therapeutics.
Pictor Labs and Pramana partner for on-demand virtual staining
A newly announced partnership will see Pictor Labs' ReStain virtual staining technology integrated directly into Pramana’s advanced SpectralHT scanners.
Advancing autonomous robotic phlebotomy
Chicago-based healthcare system Northwestern Medicine has entered into a new collaboration with Vitestro, which will include testing of Vitestro's autonomous robotic phlebotomy device Aletta.
Collaboration brings AI tools to dermatopathology
Digital pathology firm Gestalt, and Primaa, a MedTech pioneer specialising in AI-based dermatopathology solutions, have announced a strategic partnership.
Latest Issues
Launch Diagnostics is one of the major independent distributors in the U.K, providing high quality diagnostic reagents and instrumentation from world leading manufacturer’s to the Health Services of the United Kingdom, France, Belgium, Netherlands, Luxemburg and North Africa and to the Republic of Ireland through ACCUSAY Diagnostics.
2nd Global Summit on Pathology
Rome, Italy
10-11 April, 2025
The 10 Year Plan - Clinical Innovations Expo
Jubilee Hotel and Conference Centre, Nottingham, UK
15 May, 2025
Transforming Digital Pathology & AI: The Path Forward
Royal College Of Physicians Of Edinburgh
15 May, 2025
BSMT 40th Anniversary Microbiology Conference
RAF Museum, Hendon, London NW9 5LL
15 May, 2025
LabMedUK25
Bridgewater Hall, Manchester
9-11 June, 2025